VRS
RCUS icon

Virginia Retirement Systems’s Arcus Biosciences RCUS Stock Holding History

Virginia Retirement Systems’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.15M Buy
37,350
+11,100
+42% +$274K 0.01% 710
2026
Q1 		$567K Hold
26,250
– – ﹤0.01% 733
2025
Q4 		$626K Sell
26,250
-1,250
-5% -$25.5K ﹤0.01% 706
2025
Q3 		$374K Sell
27,500
-8,700
-24% -$90.5K ﹤0.01% 810
2025
Q2 		$295K Sell
36,200
-7,800
-18% -$66.6K ﹤0.01% 842
2025
Q1 		$345K Buy
+44,000
New +$510K ﹤0.01% 851
2023
Q3 		$449K Sell
25,000
-15,200
-38% -$305K ﹤0.01% 724
2023
Q2 		$816K Sell
40,200
-18,600
-32% -$354K 0.01% 602
2023
Q1 		$1.07M Buy
58,800
+9,200
+19% +$176K 0.01% 529
2022
Q4 		$1.03M Buy
49,600
+9,400
+23% +$259K 0.01% 602
2022
Q3 		$1.05M Buy
+40,200
New +$1.06M 0.01% 563
2021
Q3 		– Sell
-10,400
Closed -$286K – 1065
2021
Q2 		$286K Buy
10,400
+1,100
+12% +$31.4K ﹤0.01% 930
2021
Q1 		$261K Buy
9,300
+100
+1% +$3.48K ﹤0.01% 1026
2020
Q4 		$239K Buy
+9,200
New +$223K ﹤0.01% 1024

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Virginia Retirement Systems's RCUS Position: Q2 2026 in Review

Virginia Retirement Systems increased its Arcus Biosciences (RCUS) stake by 42% in Q2 2026, buying an estimated $274K and bringing the position to 37,350 shares worth $1.15M. The position accounts for 0.01% of the portfolio, ranked #710.

Virginia Retirement Systems first reported a position in RCUS in Q4 2020 and has held it in 14 quarters since. 231 funds tracked by Wall St. Rank hold RCUS as of Q2 2026.

  • Virginia Retirement Systems held 37,350 shares of Arcus Biosciences worth $1.15M as of Q2 2026.
  • Virginia Retirement Systems bought 11,100 Arcus Biosciences shares in Q2 2026, an estimated $274K.
  • Arcus Biosciences made up 0.01% of Virginia Retirement Systems's portfolio in Q2 2026, its #710 holding.
  • Virginia Retirement Systems first reported a position in Arcus Biosciences in Q4 2020 and has held it in 14 quarters since.
  • 231 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2026.

Based on Virginia Retirement Systems's 13F filing for Q2 2026, filed 25 Aug 2026.